Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia - First Episode Study
Brain Imaging Study and Brief Treatment - People with Hallucinations and Delusions
Enrolling:Male and Female Patients
Study Length:1 Months
Clinic Visits:6
Age Range:Between 18 and 35 years old
IRB Number:7474
Contact: Brooke Lundgren: 646-774-5579 /
Additional Study Information:

Are you between the ages of 18-35? Do you have schizophrenia or schizoaffective disorder? Researchers at the New York State Psychiatric Institute are currently seeking participants who are interested in a brief trial of anti-psychotic medication. This study will include: - magnetic resonance imaging (MRI) - a physical exam - clinical and neurocognitive assessments over a four-week period. If all elements of the study are completed, participants can make up to $550.00. For further information about the study and your eligibility, please contact us.

Do You Qualify?
Are you between the ages of 18-35?YesNo
Have you ever had unusual thoughts, experiences or feelings?YesNo
Lawrence Kegeles, MD
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Brooke Lundgren
Phone: 646-774-5579